Pro Data Export
Cardiome Pharma Corporation Key Statistics
Current Valuation
Dividends and Shares
| Shares Outstanding | 12.47M |
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Latest Dividend Date | |
| Latest Ex-Dividend Date | |
| Last Split Factor | 0.20 |
| Last Split Date | April 12, 2013 |
Profitability
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 1.165 |
| Debt to Equity Ratio | 4.135 |
| Free Cash Flow | -5.421M |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | 13.16% |
| Year to Date Stock Returns | 11.63% |
| 1 Year Stock Returns | -2.27% |
| 3 Year Stock Returns | -94.67% |
| 52 Week High | 2.684 |
| 52 Week Low | 1.20 |
Income Statement
Cash Flow Statement
| Cash from Financing TTM | 18.07M |
| Cash from Investing TTM | -0.433M |
| Cash from Operations TTM | -25.10M |
| Capital Expenditures Quarterly Pro | Go Pro |
Balance Sheet
| Cash and ST Investments | 41.27M |
| Long Term Debt | 32.50M |
| Total Assets | 44.79M |
| Liabilities | 36.93M |
| Shareholders Equity | 7.859M |
| Book Value | 7.859M |
| Book Value Per Share | 0.6302 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
CRME News
Cardiome Pharma Management Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 13
Seeking Alpha May 13
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CRME | 2.15 | +0.03 | +1.42% | 26.81M |
New watchlist
